InvestorsHub Logo
Followers 23
Posts 2036
Boards Moderated 0
Alias Born 12/06/2017

Re: DragonBear post# 123663

Thursday, 05/14/2020 11:34:07 AM

Thursday, May 14, 2020 11:34:07 AM

Post# of 144823
lol Dr Hidalgo Is one of the top liver cancer doctors in the world so I guess he does know a bit more anyone about PC and liver cancer. Where does  he works  Weil Cornell and most Dr.s respects his opinion and past work. He has saved and helped many people live. He is regarded as a top Liver Cancer doctor in the world
he is the One that designed our trial and is the PI.

Commenting on PharmaCyte’s clinical trial, renowned oncologist and clinician Dr. Manuel Hidalgo , who will be the Principal Investigator for the trial, said, “The primary goal of the study is to determine the efficacy of this approach, compared to a standard of care treatment, in controlling LAPC. If this endpoint is met, the technology will be validated as a therapeutic option in patients with LAPC.” 
Dr. Hidalgo also knows the significance of shrinking tumors in patients with LAPC and stated, “Patients who undergo a successful operation may be indeed cured of the disease. So, if this strategy is able to increase the number of patients that can undergo surgery to remove their previously inoperable tumors, that could be a very important finding.”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News